A Review on Intranasal Covid Vaccines for SARS-CoV-2
R. Santosh Kumar & Pranathi Karanam · Asian Journal of Medicine and Health · 2022
As the nasal mucosa is generally the first site of infection, intranasal vaccinations have a distinct advantage over conventional COVID-19 vaccines. According to preclinical and clinical investigations, intranasal vaccination results in significant neutralizing antibody productio...
Open access
Research Article
10.9734/ajmah/2022/v20i930492